Internal Medicine · Enterprise, AL
NPI
1437199908
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
101 E Brunson St, Suite 200
Enterprise, AL, 36330
Phone (334) 393-3686
Groups this clinician bills Medicare through
Medicare paid, 2024
$241K
12,360 services
Medicare patients, 2024
510
Average age 75
Drug cost, 2024
$2.1M
17,769 prescriptions
Company payments, 2025
$1,545
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by William A Gammill was code J1010 (injection, methylprednisolone acetate, 1 mg), 2,734 times for 33 patients. In total William A Gammill billed 12,360 services in 125 codes, and Medicare paid $241K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-03-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 2,734 | 33 | $0.09 | $236 |
| 99214 Office E&M - Established | Office | 860 | 397 | $74.54 | $64K |
| 85025 Blood Count | Office | 697 | 386 | $7.59 | $5,290 |
| 80053 Clinical Chemistry | Office | 672 | 384 | $10.31 | $6,926 |
| 84443 Clinical Chemistry | Office | 651 | 387 | $16.32 | $11K |
| 80061 Clinical Chemistry | Office | 646 | 383 | $13.03 | $8,417 |
| 81003 Clinical Chemistry | Office | 578 | 350 | $2.17 | $1,257 |
| 36415 Venipuncture Blood Collection | Office | 473 | 335 | $8.63 | $4,083 |
| 84439 Clinical Chemistry | Office | 451 | 351 | $8.75 | $3,948 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 397 | 43 | $0.07 | $29.09 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 394 | 44 | $43.78 | $17K |
| 83036 Blood Count | Office | 321 | 208 | $9.50 | $3,048 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 300 | 300 | $117.58 | $35K |
| 82570 Clinical Chemistry | Office | 245 | 159 | $5.06 | $1,240 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 225 | 41 | $34.67 | $7,800 |
By year: 2022 $245K for 10,533 services; 2023 $277K for 9,759 services; 2024 $241K for 12,360 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 697 | 386 | $7.59 | $5,290 |
| 80053 Clinical Chemistry | 672 | 384 | $10.31 | $6,926 |
| 84443 Clinical Chemistry | 651 | 387 | $16.32 | $11K |
| 80061 Clinical Chemistry | 646 | 383 | $13.03 | $8,417 |
| 81003 Clinical Chemistry | 578 | 350 | $2.17 | $1,257 |
| 36415 Venipuncture Blood Collection | 473 | 335 | $8.63 | $4,083 |
| 84439 Clinical Chemistry | 451 | 351 | $8.75 | $3,948 |
| 83036 Blood Count | 321 | 208 | $9.50 | $3,048 |
| 82570 Clinical Chemistry | 245 | 159 | $5.06 | $1,240 |
| 82043 Clinical Chemistry | 199 | 152 | $5.64 | $1,122 |
Medicare prescription drug claims, 2024
In 2024, the drug William A Gammill prescribed most often to Medicare patients was Levothyroxine Sodium, with 648 prescriptions and refills. In total William A Gammill wrote 17,769 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 648 | 1,616 | 153 | $9,423 |
| Atorvastatin Calcium Generic | 569 | 1,394 | 145 | $7,210 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 494 | 494 | 64 | $14K |
| Omeprazole Generic | 487 | 1,248 | 131 | $7,945 |
| Lisinopril Generic | 458 | 1,184 | 118 | $3,751 |
| Pantoprazole Sodium Generic | 435 | 1,059 | 119 | $5,696 |
| Gabapentin Generic | 433 | 602 | 80 | $6,553 |
| Amlodipine Besylate Generic | 423 | 1,071 | 114 | $3,296 |
| Tramadol Hcl Generic | 398 | 404 | 74 | $3,602 |
| Meloxicam Generic | 379 | 860 | 100 | $2,752 |
| Rosuvastatin Calcium Generic | 375 | 977 | 104 | $6,351 |
| Metformin Hcl Generic | 365 | 968 | 106 | $3,230 |
| Losartan Potassium Generic | 344 | 970 | 98 | $3,542 |
| Jardiance Empagliflozin | 305 | 497 | 59 | $284K |
| Alprazolam Generic | 299 | 303 | 45 | $1,988 |
Brand drugs: 2,752 claims; generic drugs: 14,928 claims; opioid claims: 1,210.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid William A Gammill $1,545 ($1,545 in general payments such as food, travel and fees) from 19 companies. The largest payer was Axsome Therapeutics, Inc. with $245.
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. AXSM | 9 | $245 |
| Amgen Inc. AMGN | 10 | $209 |
| Pfizer Inc. PFE | 12 | $194 |
| Lilly USA, LLC LLY | 19 | $184 |
| Novo Nordisk Inc NVO | 13 | $155 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 10 | $136 |
| GlaxoSmithKline, LLC. GSK | 4 | $76.15 |
| Abbvie Inc. ABBV | 4 | $66.06 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $53.66 |
| Inspire Medical Systems, Inc. INSP | 2 | $40.24 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.